Press Release

MALVERN, Pa., May 31, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, today announced that Dr. Neal Walker, President & Chief Executive Officer, will present at three upcoming investor conferences in June.

Jefferies 2016 Healthcare Conference
June 8, 2016, 3:00 p.m. EDT
Grand Hyatt, New York City

William Blair’s 35^th Annual Growth Stock Conference
June 15, 2016, 9:20 a.m. CDT
Four Seasons Hotel, Chicago

JMP Securities Life Sciences Conference
June 22, 2016, 11:30 a.m. EDT
The St. Regis, New York City

A live audio webcast of the Aclaris presentations may be accessed by visiting the “Investors” section of the Company’s website at www.aclaristx.com. A replay of the webcasts will be archived on the Aclaris website for 14 days following the presentation dates.

About Aclaris
Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated drugs to address significant unmet needs in dermatology.  Aclaris Therapeutics, Inc. is based in Malvern, Pennsylvania and more information can be found by visiting the company’s website at www.aclaristx.com.

Contact: 
Aclaris Contact
Frank Ruffo
Chief Financial Officer
484-324-7933
investors@aclaristx.com

Investor Contact
Patricia L. Bank
Westwicke Partners
Managing Director
415-513-1284
patti.bank@westwicke.com

Media Contact
Mike Beyer
Sam Brown, Inc.
312-961-2502
mikebeyer@sambrown.com

Aclaris Therapeutics, Inc.